These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 36633681
1. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma. Zhao L, Zheng Z, Liu Y, Liu F, Li X, Wu Z. J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681 [Abstract] [Full Text] [Related]
10. Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma. Prasoppokakorn T, Buntho A, Ingrungruanglert P, Tiyarattanachai T, Jaihan T, Kulkraisri K, Ariyaskul D, Phathong C, Israsena N, Rerknimitr R, Treeprasertsuk S, Chaiteerakij R. Sci Rep; 2022 Nov 04; 12(1):18686. PubMed ID: 36333384 [Abstract] [Full Text] [Related]
11. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls. Kelley RK, Magbanua MJ, Butler TM, Collisson EA, Hwang J, Sidiropoulos N, Evason K, McWhirter RM, Hameed B, Wayne EM, Yao FY, Venook AP, Park JW. BMC Cancer; 2015 Mar 31; 15():206. PubMed ID: 25884197 [Abstract] [Full Text] [Related]
12. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection. Zhou Y, Wang B, Wu J, Zhang C, Zhou Y, Yang X, Zhou J, Guo W, Fan J. BMC Cancer; 2016 Jul 20; 16():506. PubMed ID: 27439521 [Abstract] [Full Text] [Related]
13. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Qi LN, Xiang BD, Wu FX, Ye JZ, Zhong JH, Wang YY, Chen YY, Chen ZS, Ma L, Chen J, Gong WF, Han ZG, Lu Y, Shang JJ, Li LQ. Cancer Res; 2018 Aug 15; 78(16):4731-4744. PubMed ID: 29915159 [Abstract] [Full Text] [Related]
14. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses. Yin LC, Luo ZC, Gao YX, Li Y, Peng Q, Gao Y. Biomed Res Int; 2018 Aug 15; 2018():3789613. PubMed ID: 30046595 [Abstract] [Full Text] [Related]
15. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis. Cui K, Ou Y, Shen Y, Li S, Sun Z. Medicine (Baltimore); 2020 Oct 02; 99(40):e22242. PubMed ID: 33019399 [Abstract] [Full Text] [Related]
16. Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors. Wei HW, Qin SL, Xu JX, Huang YY, Chen YY, Ma L, Qi LN. Cancer Med; 2023 Jul 02; 12(14):15065-15078. PubMed ID: 37337754 [Abstract] [Full Text] [Related]
17. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients. Chen J, Cao SW, Cai Z, Zheng L, Wang Q. Cancer Biomark; 2017 Dec 06; 20(4):487-498. PubMed ID: 28869439 [Abstract] [Full Text] [Related]